JILL AWTREY: Open Payments
NPI 1295789949 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 30 payments from 6 companies in 2025. Trend: 2023 $358 · 2024 $97 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $391 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Alkermes, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, Auvelity, FANAPT, CAPLYTA, ARISTADA, REXULTI.
Industry payments across TX — which companies pay providers there.
